Article (Scientific journals)
Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial.
Palmedo, H.; Biersack, H. J.; Lastoria, S. et al.
1998In European Journal of Nuclear Medicine, 25 (4), p. 375-85
Peer Reviewed verified by ORBi
 

Files


Full Text
Palmedo H et al, Eur J Nucl Med 1998.pdf
Publisher postprint (339.88 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Breast Neoplasms/epidemiology/radionuclide imaging; Female; Humans; Middle Aged; Predictive Value of Tests; Prospective Studies; ROC Curve; Radiopharmaceuticals/diagnostic use; Sensitivity and Specificity; Technetium Tc 99m Sestamibi/diagnostic use
Abstract :
[en] The aim of the trial was to determine the diagnostic accuracy of scintimmammography with technetium-99m methoxyisobutylisonitrile (99mTc-MIBI) in the detection of primary breast cancer and to verify its clinical usefulness. A total of 246 patients with a suspicious breast mass or positive mammogram were included in this prospective European multicentre trial. At 5 min and 60 min (optional) p.i. two lateral prone images were acquired for 10 min each; 30 min p.i. one anterior image was acquired for 10 min. There were 253 lesions (195 palpable and 58 non-palpable), in respect of which histology revealed 165 cancers and 88 benign lesions. Institutional and blinded read results were correlated to core laboratory histopathology results obtained during excisional biopsy. Diagnostic accuracy for the detection of breast cancer was calculated per lesion. The overall sensitivity and specificity of blinded read scintimammography were 71% and 69%, respectively. For palpable lesions, the sensitivity of blinded read and institutional read scintimammography was 83% and 91%, respectively. Sensitivity was not dependent on the density of the breast tissue. Invasive ductal and invasive lobular cancers showed similar sensitivity. The sensitivity and specificity of mammography were 91% and 42%, respectively, and did not depend on the tumour size. In 60% of false-negative mammograms, 99mTc-MIBI was able to diagnose malignancy (true-positive). High-quality imaging with 99mTc-MIBI has a high diagnostic accuracy for the detection of primary breast cancer. Used as a complementary method, scintimammography with 99mTc-MIBI can help to diagnose breast cancer at an earlier stage in patients with dense breasts.
Disciplines :
Radiology, nuclear medicine & imaging
Author, co-author :
Palmedo, H.
Biersack, H. J.
Lastoria, S.
Maublant, J.
Prats, E.
Stegner, H. E.
Bourgeois, P.
Hustinx, Roland  ;  Université de Liège - ULiège > Département des sciences cliniques > Médecine nucléaire
Hilson, A. J.
Bischof-Delaloye, A.
Language :
English
Title :
Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial.
Publication date :
1998
Journal title :
European Journal of Nuclear Medicine
ISSN :
0340-6997
eISSN :
1432-105X
Publisher :
Springer Verlag, Heidelberg, Germany
Volume :
25
Issue :
4
Pages :
375-85
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 05 March 2009

Statistics


Number of views
86 (0 by ULiège)
Number of downloads
261 (0 by ULiège)

Scopus citations®
 
139
Scopus citations®
without self-citations
128
OpenCitations
 
84

Bibliography


Similar publications



Contact ORBi